As a UCLA spinoff, SparkGene is a biotech company focused on accelerating the development of cell therapy and making it more affordable. Our technology, CellPresso, is a novel microfluidic system with the power to increase gene editing efficiency by 10 times through a purely mechanical mechanism named 'Cell Massage'.